Explore 3 Stock Ideas & Industry Insights Download Free Report

Cellebrite DI

Technology US CLBT

13.43USD
-0.38(2.75%)

Last update at 2026-06-08T20:00:00Z

Day Range

13.2213.90
LowHigh

52 Week Range

11.0220.53
LowHigh

Fundamentals

  • Previous Close 13.81
  • Market Cap3337.50M
  • Volume1318623
  • P/E Ratio43.16
  • Dividend Yield-%
  • EBITDA78.35M
  • Revenue TTM475.68M
  • Revenue Per Share TTM1.97
  • Gross Profit TTM 400.50M
  • Diluted EPS TTM0.31

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 90.68M -275.98400M -75.56300M 120.76M 82.31M
Minority interest - - - - -
Net income 78.33M -283.00700M -81.10000M 120.81M 71.40M
Selling general administrative 65.33M 50.90M 43.44M 40.85M 47.94M
Selling and marketing expenses 154.81M 132.39M 110.81M 97.39M 76.39M
Gross profit 400.50M 338.61M 271.88M 219.91M 203.69M
Reconciled depreciation 11.87M 10.61M 9.92M 9.19M 7.09M
Ebit 66.48M 56.91M -74.81000M 1.04M 13.82M
Ebitda 78.35M 67.51M -64.79900M 10.24M 20.91M
Depreciation and amortization 11.87M 10.61M 10.01M 9.19M 7.09M
Non operating income net other - - - - -
Operating income 66.48M 56.91M 33.24M 1.04M 13.82M
Other operating expenses 409.19M 344.30M 291.87M 269.61M 232.42M
Interest expense 0.52M 349.76M 0.14M 119.72M 68.48M
Tax provision 12.35M 7.02M 5.26M -0.04500M 10.91M
Interest income 23.94M 18.22M 8.89M 1.60M 68.48M
Net interest income 23.46M -331.54100M -82.87300M 119.72M 68.48M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 12.35M 7.02M 5.54M -0.04500M 10.91M
Total revenue 475.68M 401.20M 325.11M 270.65M 246.25M
Total operating expenses 334.02M 281.70M 238.64M 218.86M 189.87M
Cost of revenue 75.17M 62.59M 53.23M 50.75M 42.56M
Total other income expense net 24.20M -332.89000M -108.80000M 119.72M 68.48M
Discontinued operations - - - - -
Net income from continuing ops 78.33M -283.00700M -59.37500M 120.81M 71.40M
Net income applicable to common shares - - - 120.81M 70.43M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 938.85M 690.57M 540.40M 403.29M 339.78M
Intangible assets 81.47M 11.31M 10.59M 11.25M 11.23M
Earning assets - - - - -
Other current assets 26.23M 29.07M 25.80M 17.09M 12.82M
Total liab 454.53M 354.55M 506.19M 329.43M 413.13M
Total stockholder equity 484.32M 336.02M 34.21M 73.86M -73.34900M
Deferred long term liab - - - - -
Other current liab 348.83M 61.91M 43.98M 45.45M 54.04M
Common stock - - - - -
Capital stock 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Retained earnings -86.53800M -164.86400M 118.14M 199.24M 78.44M
Other liab - - - 111.30M 226.56M
Good will 119.56M 28.71M 26.83M 26.83M 26.83M
Other assets - - - 14.24M 11.76M
Cash 124.46M 191.66M 189.52M 87.64M 145.97M
Cash and equivalents - - - - -
Total current liabilities 369.66M 295.50M 253.82M 207.78M 186.57M
Current deferred revenue - 217.64M 196.59M 152.71M 122.98M
Net debt -101.78700M -180.69000M -175.38800M -72.28900M -145.97300M
Short term debt 4.00M 4.12M 4.97M 5.00M -
Short long term debt - - - - -
Short long term debt total 22.67M 10.97M 14.13M 15.36M -
Other stockholder equity 568.64M 498.80M -84.98100M -125.70900M -153.15700M
Property plant equipment - - - 32.91M 16.76M
Total current assets 575.85M 567.59M 416.53M 295.93M 273.21M
Long term investments 97.96M 36.60M 28.86M 22.12M -
Net tangible assets - - - 35.78M -111.40400M
Short term investments 312.59M 255.56M 113.41M 95.98M 35.59M
Net receivables 104.97M 82.36M 77.27M 78.76M 67.50M
Long term debt - - - - -
Inventory 7.60M 8.94M 10.54M 10.18M 6.51M
Accounts payable 16.83M 11.08M 8.28M 4.61M 9.55M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 2.22M 2.09M 1.05M 0.33M 1.37M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 25.50M 7.68M 12.89M 1.73M 1.96M
Deferred long term asset charges - - - - -
Non current assets total 363.00M 122.97M 123.86M 107.36M 66.57M
Capital lease obligations 22.67M 10.97M 14.13M 15.36M -
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -107.56900M -149.47300M -63.14400M -91.23100M 73.34M
Change to liabilities - - - 33.49M 26.04M
Total cashflows from investing activities -268.25000M -149.47300M -22.54000M -91.23100M 45.23M
Net borrowings - - - - -
Total cash from financing activities 29.64M 20.65M 21.77M 13.97M -68.39700M
Change to operating activities - - - -19.74900M -1.60700M
Net income 78.33M -283.00700M -81.10000M 120.81M 71.40M
Change in cash -67.20200M 2.14M 101.87M -58.32800M 12.13M
Begin period cash flow 191.66M 189.52M 87.64M 145.97M 133.85M
End period cash flow 124.46M 191.66M 189.52M 87.64M 145.97M
Total cash from operating activities 168.96M 132.17M 102.06M 20.58M 36.05M
Issuance of capital stock - - - - 0.00000M
Depreciation 11.87M 10.61M 10.01M 9.19M 7.09M
Other cashflows from investing activities 0.86M -2.04300M -2.68700M - -
Dividends paid - - 0.00000M 0.00000M 100.00M
Change to inventory 1.63M 0.98M 0.24M -3.68000M -1.79800M
Change to account receivables -15.78100M -5.82900M 2.27M -12.88500M -1.95800M
Sale purchase of stock - -0.01100M - 0.00000M 0.00000M
Other cashflows from financing activities 25.05M 20.65M 21.77M 13.97M 31.60M
Change to netincome - - - -106.60300M -63.03100M
Capital expenditures 13.22M 10.61M 7.92M 9.09M 8.11M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 42.02M 42.05M 38.52M -2.81900M 20.59M
Stock based compensation 44.89M 30.57M 19.00M 13.71M 6.48M
Other non cash items 36.67M 335.96M 110.50M -117.91900M -67.86300M
Free cash flow 155.73M 121.56M 94.14M 11.49M 27.94M

Peer Comparison

Sector: Technology Industry: Software - Infrastructure

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CLBT
Cellebrite DI
-0.38 2.75% 13.43 43.16 35.71 7.02 6.89 6.15 28.36
MSFT
Microsoft Corporation
-4.93 1.18% 411.74 37.32 29.94 13.03 12.45 13.06 24.59
ORCL
Oracle Corporation
-1.86 0.87% 211.82 29.34 18.66 5.55 74.06 7.10 18.13
CRWD
Crowdstrike Holdings Inc
-12.23 1.82% 658.79 - 89.29 23.70 24.81 21.91 577.82
PANW
Palo Alto Networks Inc
-5.72 2.10% 266.33 44.57 45.05 11.98 20.70 11.82 77.11

Reports Covered

Stock Research & News

Profile

Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.

Cellebrite DI

94 Shlomo Shmelzer Road, Petah Tikva, Israel, 4970602

Key Executives

Name Title Year Born
Mr. Yossi Carmil Founder, CEO & Director 1967
Ms. Dana Gerner Chief Financial Officer 1967
Mr. Arnon Zilberman Exec. VP of Information Systems & Operations NA
Mr. Ronnen Armon Chief Products & Technologies Officer 1963
Anat Earon-Heilborn VP of Investor Relations NA
Ms. Ayala Berler Shapira Gen. Counsel NA
Adam Jaffe VP of Global Communications NA
Ms. Osnat Tirosh Chief People & Corp. Devel. Officer 1969
Ms. Lisa Cole Chief Marketing Officer NA
Mr. Leeor Ben-Peretz Chief Strategy Officer 1976

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.